Skip to main content
Log in

Risk factors for myelodysplastic syndromes: a case–control study in Greece

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objective: The etiology of most cases of myelodysplastic syndromes (MDS) has not been elucidated. We have undertaken an investigation in Greece to determine the risk profile of adult de-novo MDS. Methods: A case–control investigation was conducted in a large Veterans' hospital over a five-year period, covering 84 MDS cases and 84 age- and gender-matched controls with minor non-neoplastic non-infectious conditions from the same study base. Cases and controls reported to the medically trained principal investigator lifestyle characteristics and medical histories, with emphasis on autoimmune disorders and allergic conditions. Results: Alcohol intake and tobacco smoking jointly increased significantly the risk of MDS (odd ratio contrasting ever smokers and regular drinkers of at least one glass per day to never smokers and drinkers of less than one glass per day: 9.54, 95% CI 3.52–25.82) whereas each of these factors alone had limited effect. There was also evidence that autoimmune conditions, but not allergic disorders, were positively associated with MDS risk, irrespective of their occurrence during the recent (less than ten years) or the remote (more than ten years) past (OR 3.34, 95% CI 1.15–9.74; OR 3.50, 95% CI 1.19–10.26, respectively). Conclusion: We found evidence that both exogenous and endogenous factors may play a role in the etiology of the so-called “de novo” myelodysplastic syndromes, but these findings need further confirmation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Block M, Jacobsen LO, Bethard WF (1953) Preleukemic acute human leukemia. JAMA 152: 1018–1028.

    Google Scholar 

  2. Rheingold JJ, Kaufman R, Adelson E, Lear A (1963) Smoldering acute leukemia. N Engl J Med 268: 812–815.

    Google Scholar 

  3. List AF, Doll DF (1999) The myelodysplastic syndromes. In: Foerster GR, Lukens LJ, Paraskevas F, Greer JP, Rodgers GM, eds. Wintrobe's Clinical Hematology, 10th edn. Baltimore: Williams & Wilkins, pp. 2320–2333.

    Google Scholar 

  4. Aul C, Germing U, Gattermann N, Minning H (1998) Increasing incidence of myelodysplastic syndromes: real or fictitious? Leuk Res 22: 93–100.

    Google Scholar 

  5. San Miguel JF, Sanz GF, Vallespi T, del Canizo MC, Sanz MA (1996) Myelodysplastic syndromes. Crit Rev Oncol Hematol 23: 57.

    Google Scholar 

  6. Ahmad YH, Kiehl R, Papac RJ (1995) Myelodysplasia: the clinical spectrum of 51 patients. Cancer 76: 869–874.

    Google Scholar 

  7. Aul C, Gattermann N, Schneider W (1992) Age-related incidence and other epidemiologic aspects of myelodysplastic syndromes. Br J Haematol 82: 358.

    Google Scholar 

  8. Bennett M, Catovsky D, Daniel MT, Flandrin G, Galton DA, Granlick HR, Sultan S (1982) Proposals for the classification of MDS. Br J Haematol 51: 189.

    Google Scholar 

  9. Pasqualetti P, Festuccia V, Acitelli P, Collacciani A, Giusti A, Casale R (1997) Tobacco smoking and risk of hematological malignancies in adults: a case-control study. Br J Haematol 97: 659–662.

    Google Scholar 

  10. Bjork J, Albin M, Mauritzon N, Stromberg U, Johansson B, Hagmar L (2000) Smoking and myelodysplastic syndromes. Epidemiology 11: 285–291.

    Google Scholar 

  11. Ido M, Nagata C, Kawakami N, et al. (1996) A case-control study of myelodysplastic syndromes among Japanese men and women. Leuk Res 20: 727–731.

    Google Scholar 

  12. Isomaki HA, Hakulinen T, Jousenlanti U (1978) Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chron Dis 31: 691–696.

    Google Scholar 

  13. Morimoto C, Reinherz EL, Schlossman SF, Mills JA, Steinberg AD (1980) Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest 66: 1171–1174.

    Google Scholar 

  14. Talal N, Bunim JJ (1964) The development of malignant lymphoma in the course of Sjogren's syndrome. Am J Med 36: 529–540.

    Google Scholar 

  15. Sridama V, Pacini F, DeGroat LJ (1982) Decreased suppressor Tlymphocytes in autoimmune thyroid diseases detected by monoclonal antibodies. J Clin Endocrinol Metab 54: 316–319.

    Google Scholar 

  16. Luraschi A, Saglietti G, Fedeli P, et al. (1994) Immunologic indices in myelodysplastic syndromes. Minerva Med 85: 145–153.

    Google Scholar 

  17. Enright H, Miller W (1997) Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymph 24: 483–489.

    Google Scholar 

  18. Okamoto T, Okada M, Mori A (1997) Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients. Int J Hematol 66: 345–351.

    Google Scholar 

  19. Breslow NE, Day NE (1980) Statistical Methods in Cancer Research, Vol. I: The Analysis of Case-Control Studies. Lyon: International Agency for Research on Cancer, IARC Scientific Publications No 32.

    Google Scholar 

  20. Beris P (1989) Primary clonal myelodysplastic syndromes. Semin Hematol 26: 216–233.

    Google Scholar 

  21. Adami J, Nyren O, Bergstrom R, et al. (1998) Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden). Cancer Causes Control 9: 49–56.

    Google Scholar 

  22. Severson RK (1987) Cigarette smoking and leukemia. Cancer 60: 141–144.

    Google Scholar 

  23. Kane EV, Roman E, Cartwright R, Parker J, Morgan G (1999) Tobacco and the risk of acute leukaemia in adults. Br J Cancer 81: 1228–1233.

    Google Scholar 

  24. Casagrande G, Michot F (1989) Alcohol-induced bone marrow damage; status before and after a 4-week period of abstinence from alcohol with or without disulfiram. A randomized bone marrow study in alcohol-dependent individuals. Blut 59: 231–236.

    Google Scholar 

  25. Nagata C, Shimizu H, Hirashima K, et al. (1999) Hair dye use and occupational exposure to organic solvents as risk factors for myelodysplastic syndrome. Leuk Res 23: 57–62.

    Google Scholar 

  26. Trichopoulos D (1974) Medical Statistics: Principles and Basic Methods of Biomedical Statistics. In: Parisianos Scientific Editions (Greek). Athens, pp. 63–81.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dalamaga, M., Petridou, E., Cook, F.E. et al. Risk factors for myelodysplastic syndromes: a case–control study in Greece. Cancer Causes Control 13, 603–608 (2002). https://doi.org/10.1023/A:1019573319803

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1019573319803

Navigation